2 ASX shares that may be worth researching this weekend

City Chic and Reject Shop could be two good ASX shares to think about.

| More on:
Stacks of coins in a row with each higher than the last, and a person standing on top of each one watching them grow.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The weekend could be a good time to start thinking about ASX shares that may be able to benefit from the reopening play in Australia's two biggest cities.

Some businesses have had their store profit impacted for a number of months. But they could change in the coming weeks with both NSW and Victoria expected to lessen restrictions.

The below two ASX shares could be opportunities to consider:

City Chic Collective Ltd (ASX: CCX)

City Chic is a retailer of plus-size clothing, footwear and accessories. It has a store network across Australia and New Zealand, but it also has businesses and partnerships in the northern hemisphere as well.

It's currently rated as a buy by the broker Morgan Stanley. The price target is $6.65, that suggests the City Chic share price could increase by around 5% over the next 12 months, if the broker is right. Morgan Stanley is encouraged by the recent performance of Torrid, one of City Chic's rivals in the US.

Despite all of the impacts of COVID-19 during FY21, it reported double digit growth. Sales revenue rose 32.9% to $258.5 million. The various profit levels grew faster – underlying earnings before interest, tax, depreciation and amortisation (EBITDA) rose 59.8% to $42.4 million whilst underlying net profit rose 80.6% to $24.9 million.

A key move by the ASX share during the year was buying the Evans online and wholesale business in the UK. That has made City Chic the market leader in the country. Management said the first six months of trading were pleasing, with operations profitable over the period. The integration is now complete and inventory levels are back to a commercial level.

It also bought Navabi, a European plus-size business that predominately operates in Germany.

The first eight weeks of FY22 saw continued "strong" positive top line and comparable sales growth.

Morgan Stanley puts the City Chic share price at 35x FY23's estimated earnings.

Reject Shop Ltd (ASX: TRS)

The Reject Shop is a business with a national network of discount stores.

Morgan Stanley also believes that Reject Shop shares are a buy, with a price target of $10.

The broker believes that once restrictions lift, the ASX share will be able to perform better over the next couple of years.

Morgan Stanley liked the FY21 result.

Despite sales falling by 5.1% to $778.7 million, profitability across the business increased significantly. During the year, Reject Shop reduced its cost of doing business (CODB) by approximately $22.5 million. Of that total, $8.8 million came from administrative expenses and $13.7 million from store expenses.

Some of the savings achieved by the ASX share will be re-invested to improve technology and systems across the business as it prepares for growth. At a store level, Reject Shop said that the simplification and standardisation of in-store processes during the year were main drivers of store labour reducing to 13.9% of sales, compared to 14.5% in the prior corresponding period.

Reject Shop's underlying earnings before interest and tax (EBIT) increased 110% to $9.4 million, whilst underlying net profit jumped 134% to $6.4 million.

During FY21, the company opened 10 new stores and closed three years. In FY22 it's expecting to open a further 20 stores, whilst closing five unprofitable or underperforming stores.

However, the international supply chain continues to result in higher shipping costs.

The Reject Shop share price is valued at 14x FY23 estimated earnings.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Growth Shares

3 monster stocks to hold for the next 3 years

These 3 ASX shares operate in different industries and could be worth holding for long-term growth over the next 3…

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 ASX growth shares to snap up while they're still down

Brokers see plenty of upside for these mainstay sector picks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

Why these ASX growth stocks could be much bigger in 2030 than today

These stocks have long growth runways and strong business models.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »